These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18217305)

  • 1. [Nuvaring is a novel contraception method].
    Dinov I; Batashki I; Ivanov S
    Akush Ginekol (Sofiia); 2007; 46 Suppl 2():45-46. PubMed ID: 18217305
    [No Abstract]   [Full Text] [Related]  

  • 2. The combined contraceptive vaginal ring, NuvaRing, and tampon co-usage.
    Verhoeven CH; Dieben TO
    Contraception; 2004 Mar; 69(3):197-9. PubMed ID: 14969666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal ring contraception.
    Kerns J; Darney P
    Contraception; 2011 Feb; 83(2):107-15. PubMed ID: 21237335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contraceptive vaginal ring, NuvaRing, and antimycotic co-medication.
    Verhoeven CH; van den Heuvel MW; Mulders TM; Dieben TO
    Contraception; 2004 Feb; 69(2):129-32. PubMed ID: 14759617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vaginal ring (NuvaRing®) for contraception in adolescent women.
    Bitzer J
    Gynecol Endocrinol; 2012 Feb; 28(2):125-9. PubMed ID: 21615237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.
    Ahrendt HJ; Nisand I; Bastianelli C; Gómez MA; Gemzell-Danielsson K; Urdl W; Karskov B; Oeyen L; Bitzer J; Page G; Milsom I
    Contraception; 2006 Dec; 74(6):451-7. PubMed ID: 17157101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transdermal contraception--a new beginning].
    Sigridov I; Dikov I; Ivanov S
    Akush Ginekol (Sofiia); 2004; 43 Suppl 1():19-27. PubMed ID: 15323313
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vaginal contraception: new form of administration of hormonal contraception].
    Knuist M; Hamerlynck JV
    Ned Tijdschr Geneeskd; 2003 Oct; 147(43):2095-7. PubMed ID: 14619196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraceptive vaginal ring.
    Madden T; Blumenthal P
    Clin Obstet Gynecol; 2007 Dec; 50(4):878-85. PubMed ID: 17982330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction. NuvaRing.
    Milsom I
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():11; discussion 37-9. PubMed ID: 12659396
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone.
    Milsom I; Lete I; Bjertnaes A; Rokstad K; Lindh I; Gruber CJ; Birkhäuser MH; Aubeny E; Knudsen T; Bastianelli C
    Hum Reprod; 2006 Sep; 21(9):2304-11. PubMed ID: 16763008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contraceptive vaginal ring.
    Edwardson J; Jamshidi R
    Semin Reprod Med; 2010 Mar; 28(2):133-9. PubMed ID: 20352563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual hormone levels in used contraceptive rings as a measurement of adherence to vaginal ring use.
    Haaland RE; Holder A; Evans-Strickfaden T; Nyagol B; Makanga M; Oyaro B; Humwa F; Williams T; McLellan-Lemal E; Desai M; Huey MJ
    Contraception; 2017 Jun; 95(6):602-604. PubMed ID: 28372978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete and robust ovulation inhibition with NuvaRing.
    Killick S
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():13-8; discussion 37-9. PubMed ID: 12659397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic bioequivalence, safety and acceptability of Ornibel
    Algorta J; Diaz M; de Benito R; Lefebvre M; Sicard E; Furtado M; Regidor PA; Ronchi C
    Eur J Contracept Reprod Health Care; 2017 Dec; 22(6):429-438. PubMed ID: 29336615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing patient telephone callback rates for different hormonal birth control delivery systems.
    Victor I; Fink RA
    Am J Ther; 2006; 13(6):507-12. PubMed ID: 17122531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combined etonogestrel/ethinyl estradiol contraceptive vaginal ring.
    Wagner MS; Arias RD; Nucatola DL
    Expert Opin Pharmacother; 2007 Aug; 8(11):1769-77. PubMed ID: 17685892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of the Yuzpe and levonorgestrel regimens of emergency contraception: vaginal vs. oral administration.
    Kives S; Hahn PM; White E; Stanczyk FZ; Reid RL
    Contraception; 2005 Mar; 71(3):197-201. PubMed ID: 15722070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis and new contraception frontiers with combined vaginal rings.
    Barriga Pooley P; Von Hoveling A; Galán G; López Berroa J
    Gynecol Endocrinol; 2020 Jun; 36(6):475-478. PubMed ID: 32091277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of uterine concentrations of ethinyl estradiol and etonogestrel after use of a contraceptive vaginal ring and an oral contraceptive.
    Roumen FJ; Dieben TO
    Fertil Steril; 2006 Jan; 85(1):57-62. PubMed ID: 16412731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.